Cyclerion Therapeutics Cash Flow Statement 2017-2024 | CYCN

Fifteen years of historical annual cash flow statements for Cyclerion Therapeutics (CYCN).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
2023202220212020201920182017
$-5.26$-44.08$-51.65$-77.80$-123.01$-115.25$-93.92
$0$0.07$0.47$2.30$2.70$1.53$1.75
$-11.38$6.25$13.25$10.61$20.38$12.43$9.49
$-11.38$6.32$13.72$12.90$23.08$13.96$11.24
$0.10$0.00$0.03$1.35$-1.47$0$0
$0$0$0$0$0$0$0
$-1.77$1.14$0.39$-1.10$-0.25$0.98$0.39
$-2.93$-4.00$0.99$-7.84$-0.57$2.81$1.07
$-4.60$-2.85$1.41$-7.59$-2.29$3.79$1.47
$-21.25$-40.61$-36.52$-72.49$-102.22$-97.50$-81.22
$0$0$1.46$0.02$-6.72$-3.44$-1.40
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$0$0$0$0$0$0$0
$10.40$0$0$0$0$0$0
$10.40$0$1.46$0.02$-6.72$-3.44$-1.40
$0$0$0$0$0$0$0
$0$0$0$3.51$0$0$0
$0$0$0$3.51$0$0$0
$5.02$0.03$0.28$0.33$0.51$0$0
$5.02$0.03$0.28$0.33$0.51$0$0
$0$0$0$0$0$0$0
$0$0$30.50$24.25$211$101$82.62
$5.02$0.03$30.79$28.09$212$101$82.62
$-5.81$-40.58$-4.27$-44.39$103$0$0
$1.07$6.25$9.61$14.99$19.63$12.43$9.49
$0$0$0$0$0$0$0